Project Grant R01AI188648
Award Date
11/18/24
Completion Date
10/31/29
Dollars Obligated
$521K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $222,852 to support research into the regulation of virulence factors in the pathogenic bacterium Clostridioides difficile. The primary objective is to identify and annotate Rho, NusA, and NusG dependent transcriptional terminators in C. difficile to understand how these regulatory factors influence the...
This Project Grant award of $1,005,000 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the molecular basis of ferrosome organelle biogenesis and its impact on host-microbe interactions in Clostridioides difficile, a leading cause of nosocomial and antibiotic-associated intestinal infections. The research aims to uncover the mechanisms underlying ferrosome formation and...
This $780,162 Project Grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases will fund research at Old Dominion University from August 2022 through July 2026 exploring the role of nutrient and stress sensing in regulating Clostridioides difficile physiology and behavior within the host. The research aims to determine how the stringent response regulates disease-relevant bacterial processes and characterize enzymes that mediate alarmone metabolism...
This $261,492 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the impact of DNA methylation on the physiology of Clostridioides difficile, a major nosocomial pathogen. The research aims to identify specific methylation sites that regulate C. difficile sporulation, which enhances the bacterium's ability to persist. This effort builds on prior work...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $180,310 to the University of Oklahoma Health Sciences Center to conduct research on the interactions between Clostridioides difficile toxin B (TcdB) and the host cell surface proteoglycan CSPG4. The overarching goal is to understand how CSPG4 is used by the hypervirulent TcdB2 isotype to promote the pathologies...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $1,541,024.00 to the University of Notre Dame to study the spore germination pathway of Clostridioides difficile and explore pharmacological interventions. The grant aims to: 1) elucidate the details of the spore germination pathway, 2) demonstrate that inhibiting spore germination is key to preventing recurrent C. difficile infections, and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of a novel probiotic yeast-based immunotherapy to prevent the transmission of Clostridioides difficile (C. difficile) infections. The $511,553 award to the University of Maryland, Baltimore will fund research to screen for lead bi-specific antibody fragments against the C. difficile surface protein...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $171,254 to the Nimml Institute Inc., a 501(c)(3) non-profit research organization, to elucidate novel immunometabolic mechanisms that can intercept bacterial toxin internalization and processing in order to suppress cell damage caused by Clostridioides difficile infection (CDI). The research aims to investigate...
This $894,552 project grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research at the University of Nevada, Las Vegas to probe the effect of a high-fat/high-protein diet on Clostridioides difficile infection. Specifically, the researchers will examine how such a diet impacts inflammation, intestinal permeability, and the gut microbiome before and after antibiotic...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $240,060 to the University of North Carolina at Chapel Hill to study the cellular states and organization of Vibrio cholerae biofilms, which contribute to the spread of cholera. The research aims to: 1) Measure the single-cell transcriptome of V. cholerae cells in planktonic and biofilm states to identify physiological differences; 2)...